Shore Capital Partners
Shore Capital Partners is a lower-middle-market private equity firm with extensive activity in healthcare alongside other selected sectors.
- Healthcare and life sciences private equity investment firm
- Healthcare & Life Sciences PEF
- Tier II
Overview
Shore Capital Partners is a lower-middle-market private equity firm with extensive activity in healthcare alongside other selected sectors. Its healthcare investments span provider services, products, distribution, behavioral health, veterinary services, and related markets.
The firm is known for building platforms from smaller businesses in fragmented sectors. This strategy requires management recruitment, compliance infrastructure, local market development, acquisition integration, and the introduction of systems capable of supporting rapid organizational growth. Within The Economy Wiki, the firm is connected to the Healthcare & Life Sciences PEF market category.
Firm facts
| Institution | Shore Capital Partners |
| Type | Healthcare and life sciences private equity investment firm |
| Headquarters | Chicago, United States |
| Founded | 2009 |
| Primary ranking focus | Healthcare & Life Sciences PEF |
| Highest 2026 tier | Tier II |
Activities and investment capabilities
Shore’s healthcare franchise has increased in scale while retaining an emphasis on founder-led and lower-middle-market companies. Its high level of transaction activity gives it visibility across subsectors that may be too small or operationally intensive for larger healthcare funds.
Healthcare investing
Equity investment across healthcare services, products and technology.
Life sciences exposure
Capital for pharmaceutical, biotechnology, medtech and outsourced-service platforms.
Sector value creation
Support informed by regulation, reimbursement, clinical workflows and market access.
Strategy and transaction coverage
Strategy and sector coverage
Healthcare services; life sciences; pharmaceuticals; medtech; diagnostics; healthcare IT
Transaction and ownership contexts
Buyouts; growth investments; recapitalizations; platform formation; add-on acquisitions
Market position
Shore fits Tier II because healthcare represents a major and sustained part of its investment platform. Its sourcing reach, platform-building model, and current institutional scale make it an important participant in the U.S. healthcare private equity market.
Shore Capital Partners is assessed within the Healthcare & Life Sciences PEF framework. For wider market context, see The Mid-Market Advantage in Healthcare Private Equity.
Competitive context
Shore Capital Partners is recognized Tier II in Top 30 Healthcare & Life Sciences PEF 2026. The ranking compares firms by institutional relevance, specialist capability, investment activity, operating depth and market positioning. Comparable-firm links below support navigation and do not imply that every institution competes for every transaction or asset.
Leadership and governance
Leadership, investment-committee composition and operating resources may change over time. Current information should be confirmed through Shore Capital Partners’s official website.
| Leadership area | Current source |
|---|---|
| Investment and operating leadership | Current team and governance information |
Corporate and public information
This profile refers to Shore Capital Partners as the public-facing investment organization. Individual funds, management companies, advisers and regulated entities may use separate legal names across jurisdictions.
Corporate and disclosure information
| Organization | Shore Capital Partners |
| Headquarters | Chicago, United States |
| Public website | www.shorecp.com |
| Profile basis | Public institutional information and Capital Ranking editorial research |
Ranking recognition
Related Economy analysis
Selected Economy Markets articles provide context for the investment, diligence, financing and value-creation themes relevant to this firm:
- The Mid-Market Advantage in Healthcare Private Equity
- Middle-Market Private Equity: Returns, Scale and Manager Selection
- Private Equity Technology Due Diligence in the AI Era
